Lightpoint Performs World's First Bladder Cancer SLN Procedure with SENSEI
Lightpoint Surgical Ltd., an affiliate of Telix Pharmaceuticals Ltd. has achieved a new milestone with world’s first bladder cancer sentinel lymph node (SLN) procedure with SENSEI
Gamma Probe | 27/03/2024 | By Manvi | 507
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy